Literature DB >> 24829075

A case series of α-thalassemia intermedia due to compound heterozygosity for Hb Adana [HBA2: c179G>A (or HBA1); p.Gly60Asp] with other α-thalassemias in Malay families.

Hafiza Alauddin1, Noor-Adilah Jaapar, Raja Z Azma, Azlin Ithnin, Noor-Farisah A Razak, C-Khai Loh, Hamidah Alias, Zarina Abdul-Latiff, Ainoon Othman.   

Abstract

Hb Adana [HBA2: c179G>A (or HBA1); p.Gly60Asp] is a rare hemoglobin (Hb) variant due to a mutation at codon 59 of the α2- or α1-globin gene resulting in a glycine to aspartic acid substitution. Two siblings with a unique coinheritance of Hb Adana and Hb Constant Spring (Hb CS, α142, Term→Gln, TAA>CAA; HBA2: c.427 T>C) (α(codon 59)α/α(CS)α), were compared phenotypically with another two siblings carrying the Hb Adana mutation and a 3.7 kb deletion (α(codon 59)α/-α(3.7)). Although they all had α-thalassemia intermedia (α-TI), the former were clinically more severe than the latter. The first pair of siblings presented at a much younger age than the second pair and showed lower Hb levels and significant extramedullay hemopoiesis. Another case of a hydropic fetus as a result of Hb H/Hb Adana is also described. Their clinical phenotypes and hematological parameters are all presented for comparison.

Entities:  

Keywords:  Codon 59 mutation; Hb Adana; Hb Constant Spring (Hb CS); – –SEA; −α3.7

Mesh:

Substances:

Year:  2014        PMID: 24829075     DOI: 10.3109/03630269.2014.916720

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  2 in total

1.  Α case of late diagnosis of compound heterozygosity for Hb Adana (HBA2:c.179G>A) in trans to an α+- thalassemia deletion: guilty or innocent.

Authors:  A Tampaki; S Theodoridou; Ch Apostolou; E E Delaki; E Vlachaki
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia.

Authors:  Jin Ai Mary Anne Tan; Siew Leng Kho; Chin Fang Ngim; Kek Heng Chua; Ai Sim Goh; Seoh Leng Yeoh; Elizabeth George
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.